A Phase II Pilot Study of Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults with High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant: A Multicenter Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Study (EXCEL Trial)

Is this Study for You?

Let's Get Started!


Child to Adult

Type of Study



Childrens Hospital Colorado

Principal Investigator
Photograph of Michael Verneris,  MD

Michael Verneris, MD

Study ID

Protocol Number: 21-2662

More information available at ClinicalTrials.gov: NCT04836390

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers